Minsung Cho

Minsung Cho

Auto-generated profile, based on publicly available information

Minsung Cho

Department of Public Health, Yonsei University Graduate School, Seoul, Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Clinical Hypertension
Verified
Journal Article
Open access
PDF file
HKHyeon Chang Kim
Hyeon Chang Kim
HLHokyou Lee
Hokyou Lee
HLHyeok-Hee Lee
Hyeok-Hee Lee
DSDasom Son
Dasom Son
MCMinsung Cho
Minsung Cho
EKEun-Jin Kim
Eun-Jin Kim
The Korea Hypertension Fact Sheet 2023, presented by the Korean Society of Hypertension, offers an overview of the prevalence and management of hypertension, along with recent trends. Data for the Fact Sheet were derived from the Korea National Health and Nutrition Examination Survey spanning 1998 to 2021, and the National Health Insurance Big Data from 2002 to 2021. As of 2021, hypertension affected 28.0% of Korean adults aged 20 and older, totaling approximately 12.3 million individuals, with 5.3 million (43.5%) aged 65 or older. Among those with hypertension, awareness stood at 74.1%, treatment rates at 70.3%, and control rates at 56.0%. Over the years, the number of hypertension diagnoses increased from 3.0 million in 2002 to 11.1 million in 2021. During the same period, the utilization of antihypertensive medications rose from 2.5 million to 10.5 million, with treatment adherence also improving from 0.6 million to 7.8 million individuals. In 2021, the predominant antihypertensive drug class was angiotensin receptor blockers (75.1%), followed by calcium channel blockers (61.7%), diuretics (23.4%), and beta blockers (15.3%). Notably, 60.2% of all antihypertensive prescriptions involved combination therapy with at least two classes of antihypertensive medication. There was a positive trend towards stricter blood pressure control targets (systolic/diastolic blood pressure < 130/80 mmHg) among elderly hypertensive patients, as well as those with diabetes, obesity, and high-risk hypertension. However, this trend declined in individuals aged 80 years or older and those with chronic kidney disease in recent years. In Korea, hypertension management is making strides, yet the total number of hypertensive individuals is rising. Effectively addressing the growing population of elderly hypertensive patients and the persistently low treatment rates among younger individuals with hypertension is a critical challenge. Additionally, developing more efficient and customized policies for blood pressure control and cardiovascular disease prevention is imperative.

1 January 2025 in Clinical Hypertension
Verified
Journal Article
Open access
PDF file
HKHyeon Chang Kim
Hyeon Chang Kim
HLHokyou Lee
Hokyou Lee
HLHyeok-Hee Lee
Hyeok-Hee Lee
SASong Vogue Ahn
Song Vogue Ahn
JLJu Mi Lee
Ju Mi Lee
FGfor the Korean Society of Hypertension (KSH) – Hypertension Epidemiology Research Working Group
for the Korean Society of Hypertension (KSH) – Hypertension Epidemiology Research Working Group
Kim HC, et al. Clin Hypertens. 2025 Mar;31(1):e11. https://doi.org/10.5646/ch.2025.31.e11

26 December 2023 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
MCMinsung Cho
Minsung Cho
HLHyeok-Hee Lee
Hyeok-Hee Lee
JBJang-Hyun Baek
Jang-Hyun Baek
KYKyu Sun Yum
Kyu Sun Yum
MKMin Kim
Min Kim
HKHyeon Chang Kim
Hyeon Chang Kim
OBJECTIVES: The escalating burden of cardiovascular disease (CVD) is a critical public health issue worldwide. CVD, especially acute myocardial infarction (AMI) and stroke, is the leading contributor to morbidity and mortality in Korea. We aimed to develop algorithms for identifying AMI and stroke events from the National Health Insurance Service (NHIS) database and validate these algorithms through medical record review.METHODS: We first established a concept and definition of “hospitalization episode,” taking into account the unique features of health claims-based NHIS database. We then developed first and recurrent event identification algorithms, separately for AMI and stroke, to determine whether each hospitalization episode represents a true incident case of AMI or stroke. Finally, we assessed our algorithms’ accuracy by calculating their positive predictive values (PPVs) based on medical records of algorithm-identified events.RESULTS: We developed identification algorithms for both AMI and stroke. To validate them, we conducted retrospective review of medical records for 3,140 algorithm-identified events (1,399 AMI and 1,741 stroke events) across 24 hospitals throughout Korea. The overall PPVs for the first and recurrent AMI events were around 92% and 78%, respectively, while those for the first and recurrent stroke events were around 88% and 81%, respectively.CONCLUSIONS: We successfully developed algorithms for identifying AMI and stroke events. The algorithms demonstrated high accuracy, with PPVs of approximately 90% for first events and 80% for recurrent events. These findings indicate that our algorithms hold promise as an instrumental tool for the consistent and reliable production of national CVD statistics in Korea.

1 January 2026 in Clinical Hypertension
Verified
Journal Article
Open access
PDF file
HKHyeon Chang Kim
Hyeon Chang Kim
HLHokyou Lee
Hokyou Lee
HCHansol Choi
Hansol Choi
HKHayan Kwon
Hayan Kwon
JLJaeyong Lee
Jaeyong Lee
FGfor the Korean Society of Hypertension (KSH) – Hypertension Epidemiology Research Working Group
for the Korean Society of Hypertension (KSH) – Hypertension Epidemiology Research Working Group
Kim HC, et al. Clin Hypertens. 2026 ;32(1):e13. https://doi.org/10.5646/ch.2026.32.e13

23 October 2026 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
JKJaewon Khil
Jaewon Khil
SSSojung Shin
Sojung Shin
SSSeo Jeong Shin
Seo Jeong Shin
JLJaeyong Lee
Jaeyong Lee
MCMinsung Cho
Minsung Cho
HKHyeon Chang Kim
Hyeon Chang Kim
Khil J, et al. Korean Circ J. 2027 ;57:e40. https://doi.org/10.4070/kcj.2026.0060

31 October 2025 in Cardiovascular Prevention and Pharmacotherapy
Verified
Journal Article
Open access
MCMinsung Cho
Minsung Cho
JHJiyen Han
Jiyen Han
HCHansol Choi
Hansol Choi
JSJee-Seon Shim
Jee-Seon Shim
SJSun Jae Jung
Sun Jae Jung
HKHyeon Chang Kim
Hyeon Chang Kim
Background: The clinical significance of isolated diastolic hypertension (IDH), particularly in relation to subclinical vascular changes, remains unclear and may vary across age groups. This study evaluated the age-stratified association between IDH and carotid intima-media thickness (IMT).Methods: This cross-sectional study included 6,759 Korean adults aged 30–64 years from the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) cohort. Participants with a history of cardiovascular disease or use of antihypertensive medication were excluded. Blood pressure was classified according to the 2017 American College of Cardiology/American Heart Association guidelines into four categories: no hypertension, IDH, isolated systolic hypertension, and systolic diastolic hypertension. Carotid IMT was measured by B-mode ultrasonography, and vascular thickening was defined as IMT ≥0.857 mm (75th percentile). Multivariable logistic regression analyses were performed with age stratification.Results: Among participants younger than 50 years, IDH was significantly associated with carotid IMT thickening after adjustment for age, sex, body mass index, educational attainment, physical activity, smoking, diabetes, total cholesterol, high-density lipoprotein cholesterol, lipid-lowering drug use, C-reactive protein, and study site (odds ratio [OR], 1.57; 95% confidence interval [CI], 1.10–2.26). No significant association was observed in participants aged 50 years or older (OR, 0.89; 95% CI, 0.72–1.09). Both isolated systolic hypertension and systolic diastolic hypertension were associated with carotid IMT thickening in all age groups.Conclusions: IDH was associated with subclinical vascular changes in younger adults but not in older adults. These findings highlight the age-specific nature of the association of IDH with cardiovascular risk.